GPⅡb/Ⅲa受体拮抗剂在急性冠状动脉综合征的临床应用进展
出处
《吉林医学》
CAS
2006年第7期848-850,共3页
Jilin Medical Journal
参考文献19
-
1Ferguson JJ,Lau TK.New antiplatelet agents for acute coronary syndromes[J].Am Heart J,1998,135:S194.
-
2Peerlinck K,De-Lepeleire I,Goldberg M,et al.A selective nonpeptide platelet glycoprotein Ⅱ b/Ⅲa antagonist,it active in man[J].Circulation,1993 ,88(4):1512.
-
3黄震华,徐济民.心肌缺血治疗中抗血小板药物应用进展[J].新药与临床,1997,16(4):231-233. 被引量:14
-
4Coller BS,Peerschke EI,Scudder LE,et al.A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombosthenic like state in normal platelets and binds to glycoproteins Ⅱb and/or Ⅲa[J].J Clin Invest,1983, 72:325.
-
5The EPISTENT Investigators.Randomised placebo controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-Ⅱ b/Ⅲ a blockade.Evaluation of Platelet Ⅱ b/Ⅲ a Inhibitor for Stentins[J].Lancet,1998, 352:87.
-
6The EPIC Investigators.Use of monoclonal antibody directed against the platelet glycoproteinⅡb/Ⅲa receptor in highrisk coronary angioplasty[J].N Engl J Med,1994,330(14):956.
-
7Simoons ML,GUSTO Ⅳ-ACS Investigators.Effect of Glycopro tein Ⅱ b/Ⅲ a receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascu larisation:the GUSTO Ⅳ-ACS randomised trial[J].Lancet,2001 ,357(9272):1915.
-
8Scarborough RM,Naughton MA,Teng W,et al.Design of potent and specific integrin antagonists.Peptide antagonists with high specificity for glycoprotein Ⅱ b/Ⅲ a[J].J Biol Chem,1993, 268:1066.
-
9Jennings L,Tardiff B,Philips D,et al.Comparison of recept or occupancy and platelet aggregation response of epifibatide administered intravenously in patients with unstable angina or non Q wave myocardial infarction[J].J Am Coll Cardiol,1998 ,31 (2A):93A.
-
10Mahaffey KW,Harrington RA,Simoons ML,et al.Stroke in patients with acute coronary syndromes:Incidence and outcomes in the platelet glycoprotein Ⅱ b/Ⅲ a in unstable angina.Receptor suppression using integrilin therapy (PURSUIT) trial.The PURSUIT Investigators[J].Circulation,1999, 99(18):2371.
二级参考文献1
-
1Kun S K,Am J Physiol,1994年,267卷,H488页
共引文献13
-
1汤军.血小板糖蛋白IIb/IIIa受体阻断药[J].医药导报,2002,21(S1):94-95.
-
2吕莎,廖庆斌.前列地尔对冠心病患者血脂及血液流变学的影响[J].中国药业,2006,15(8):47-48. 被引量:4
-
3方哲,金海,周玉杰,李艳芳,李月平.GP IIb/IIIa受体拮抗剂在急性冠脉综合征的临床进展[J].吉林医学,2007,28(2):150-153. 被引量:8
-
4白莹,田国平.血小板GP Ⅱb/Ⅲa受体拮抗剂在ACS中的应用[J].中国心血管病研究,2007,5(10):780-782. 被引量:4
-
5徐文华.前列地尔联合肝素钠治疗急性冠脉综合征疗效观察[J].中国基层医药,2010,17(23):3229-3230. 被引量:2
-
6黄震华,朱文敏,许左隽,顾燕,胡余.噻氯匹定和阿司匹林降低血液粘度和抗血小板作用的比较[J].中国新药与临床杂志,1999,18(6):347-348. 被引量:4
-
7韦爱芳.前列腺素E_1治疗冠心病的疗效观察[J].广西医科大学学报,2000,17(2):277-278. 被引量:1
-
8黄震华.阿司匹林作用再评价和抗血小板治疗进展[J].中国综合临床,2000,16(5):322-324. 被引量:4
-
9梁文学,程建,王飞.高龄冠脉慢性闭塞病变PCI术后小剂量替罗非班的安全性观察[J].现代诊断与治疗,2013,24(2):277-279.
-
10黄震华.新型抗血小板药物eptifibatide[J].中国新药杂志,2000,9(12):820-823. 被引量:4
-
1梁玉华.急性冠脉综合征65例护理体会[J].安徽医药,2005,9(7):551-552. 被引量:7
-
2李凤婷.急诊PCI术后应用受体拮抗剂替罗非班的护理[J].中国实用护理杂志(中旬版),2010(5):14-15. 被引量:2
-
3本刊常用的不需要标注中文的缩略语[J].中国中西医结合急救杂志,2012,19(1):57-57.
-
4何茉莉,杨可.急性冠状动脉综合征患者胸痛的护理[J].现代中西医结合杂志,2007,16(26):3898-3899. 被引量:1
-
5睢德道.危及生命的急性胸痛156例临床分析[J].吉林医学,2009,30(23):3013-3014. 被引量:6
-
6祝雪莉.前馈控制在急性冠脉综合征患者护理安全管理中的应用[J].中国初级卫生保健,2012,26(1):103-104. 被引量:1
-
7继续教育答题[J].中华现代护理杂志,2009,15(11):1095-1095.
-
8张正侠.急诊PCI治疗ST段抬高心肌梗死的护理探讨[J].中国医药科学,2014,4(24):110-112. 被引量:4
-
9杜莉群,王玉蓉.急性心肌梗死静脉溶栓治疗的观察与护理[J].内蒙古中医药,2011,30(5):153-154.
-
10宋杰.非ST段抬高心肌梗死患者血清NE、BNP与心功能及病变程度的相关性[J].国际医药卫生导报,2015,21(6):796-798. 被引量:1